We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $9.11B
1-Year Est. Return 26.3%
This Fund
S&P 500
This Quarter Est. Return
+15.69%
1 Year Est. Return
+26.3%
3 Year Est. Return
+74.73%
5 Year Est. Return
+70.98%
10 Year Est. Return
+244.22%
AUM
$9.11B
AUM Growth
+$968M
Cap. Flow
-$15.1M
Cap. Flow %
-0.17%
Top 10 Hldgs %
30.74%
Holding
1,803
New
190
Increased
690
Reduced
735
Closed
113

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.84%
2 Technology 12.19%
3 Financials 6.9%
4 Industrials 3.9%
5 Consumer Discretionary 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BITQ icon
1551
Bitwise Crypto Industry Innovators ETF
BITQ
$447M
$203K ﹤0.01%
+8,302
New +$210K
IBDR icon
1552
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.27B
$203K ﹤0.01%
8,389
-534
-6% -$12.9K
SIG icon
1553
Signet Jewelers
SIG
$3.31B
$203K ﹤0.01%
2,358
-104
-4% -$8.99K
CTA icon
1554
Simplify Managed Futures Strategy ETF
CTA
$1.57B
$203K ﹤0.01%
+7,822
New +$232K
IBDS icon
1555
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.92B
$203K ﹤0.01%
8,376
-531
-6% -$12.8K
CNK icon
1556
Cinemark Holdings
CNK
$4.06B
$202K ﹤0.01%
+6,368
New +$189K
GHC icon
1557
Graham Holdings Company
GHC
$4.81B
$202K ﹤0.01%
+177
New +$199K
IBDT icon
1558
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.08B
$202K ﹤0.01%
7,998
-210
-3% -$5.3K
VTWV icon
1559
Vanguard Russell 2000 Value ETF
VTWV
$1.4B
$202K ﹤0.01%
+1,033
New +$191K
CPK icon
1560
Chesapeake Utilities
CPK
$3.2B
$202K ﹤0.01%
+1,639
New +$206K
GEF icon
1561
Greif
GEF
$4.83B
$202K ﹤0.01%
+2,685
New +$180K
ARKG icon
1562
ARK Genomic Revolution ETF
ARKG
$2.02B
$202K ﹤0.01%
+4,792
New +$153K
B
1563
Barrick Mining
B
$73.7B
$201K ﹤0.01%
5,484
-10,846
-66% -$445K
ARKK icon
1564
ARK Innovation ETF
ARKK
$6.44B
$201K ﹤0.01%
+2,491
New +$190K
QLYS icon
1565
Qualys
QLYS
$5.94B
$201K ﹤0.01%
+1,465
New +$144K
PII icon
1566
Polaris
PII
$3.56B
$201K ﹤0.01%
+2,938
New +$189K
IBDV icon
1567
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.29B
$201K ﹤0.01%
+9,220
New +$201K
IBCA
1568
iShares iBonds Dec 2035 Term Corporate ETF
IBCA
$411M
$201K ﹤0.01%
+7,846
New +$201K
IBDZ
1569
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$856M
$201K ﹤0.01%
+7,712
New +$201K
IBDX icon
1570
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.76B
$201K ﹤0.01%
+7,974
New +$201K
BBWI icon
1571
Bath & Body Works
BBWI
$3.93B
$201K ﹤0.01%
+8,681
New +$166K
IBDW icon
1572
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.56B
$201K ﹤0.01%
+9,625
New +$201K
IBDY icon
1573
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.17B
$201K ﹤0.01%
+7,790
New +$201K
PNFP icon
1574
Pinnacle Financial Partners Inc
PNFP
$15.3B
$200K ﹤0.01%
+1,987
New +$191K
MD icon
1575
Pediatrix Medical
MD
$2.2B
$200K ﹤0.01%
+7,913
New +$180K

Similar funds

Choreo LLC's Q2 2026 Portfolio in Review

As of Q2 2026, Choreo LLC held 1,803 positions worth $9.11B, up 12% from $8.15B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Choreo LLC's Q2 2026 filing shows 190 new, 690 increased, 735 reduced and 113 closed positions. Its largest new stake was Janus Henderson Small Cap Growth Alpha ETF: 56,418 shares worth $5.25M. The largest sale was ExxonMobil, an estimated $31M.

By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, up from 61% a quarter earlier, followed by Technology and Financials.

  • Choreo LLC's largest Q2 2026 buy was Janus Henderson Small Cap Growth Alpha ETF: 56,418 shares worth $5.25M.
  • Choreo LLC added most to Dimensional Emerging Markets Core Equity 2 ETF in Q2 2026, an estimated $24.2M increase.
  • Choreo LLC's biggest Q2 2026 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $10.8M.
  • Choreo LLC fully exited ExxonMobil in Q2 2026, selling an estimated $31M.
  • Choreo LLC's ten largest holdings make up 31% of its $9.11B portfolio in Q2 2026.
  • Choreo LLC opened 190 new positions and closed 113 in Q2 2026.
  • Choreo LLC's portfolio value rose 12% quarter-over-quarter to $9.11B.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.